Richard M. Wright - 16 Jun 2022 Form 4 Insider Report for Celldex Therapeutics, Inc. (CLDX)

Role
SR. VP & CCO
Signature
/s/ Samuel B. Martin, attorney-in-fact for Richard M. Wright
Issuer symbol
CLDX
Transactions as of
16 Jun 2022
Net transactions value
$0
Form type
4
Filing time
17 Jun 2022, 16:19:23 UTC
Previous filing
21 Jun 2021
Next filing
17 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLDX Incentive Stock Option (right to buy) Award $0 +42,000 $0.000000 42,000 16 Jun 2022 Common Stock 42,000 $22.48 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
F2 25% vest on June 16, 2023 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.